Global Whole Transcriptomics Sequencing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Whole Transcriptomics Sequencing market size will reach US$ 8334 million by 2031.

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.

A significant driver in the Whole Transcriptomics Sequencing market is the growing demand for comprehensive insights into gene expression and regulation. Whole transcriptomics sequencing offers researchers the ability to analyze the entire transcriptome, providing valuable information on gene expression, alternative splicing, and non-coding RNAs. However, a notable challenge in this market is the need for data analysis and interpretation expertise. Ensuring that researchers can effectively analyze and derive meaningful insights from the vast amount of transcriptomic data generated poses a significant challenge. Bioinformatics tools and computational resources must be continually developed and improved to simplify data analysis and interpretation, allowing researchers to unlock the full potential of whole transcriptomics sequencing in advancing our understanding of gene function and regulation.

LPI (LP Information)' newest research report, the “Whole Transcriptomics Sequencing Industry Forecast” looks at past sales and reviews total world Whole Transcriptomics Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Whole Transcriptomics Sequencing sales for 2025 through 2031. With Whole Transcriptomics Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Whole Transcriptomics Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Whole Transcriptomics Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Whole Transcriptomics Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Whole Transcriptomics Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Whole Transcriptomics Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Whole Transcriptomics Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Whole Transcriptomics Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
PCR
Microarray
Sequencing

Segmentation by Application:
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

Please note: The report will take approximately 2 business days to prepare and deliver. Show more